DMK PHARMACEUTICALS CORP (DMK) Stock Income Statement
NASDAQ:DMK - US00547W3079 - Common Stock
0.232 USD
+0 (+0.91%)
0.1665 USD
-0.07 (-28.23%)
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.62M | 4.76M | 2.21M | 2.78M | 22.11M | |||
| Cost Of Goods | 4.97M | 6.19M | 6.87M | 6.33M | 15.48M | |||
| Gross Profit | -1.35M | -1.43M | -4.66M | -3.55M | 6.64M | |||
| Operating Expenses | 23.87M | 23.63M | 27.41M | 28.13M | 35.66M | |||
| Research and Development | 9.51M | 10.38M | 11.26M | 8.04M | 10.38M | |||
| Selling, General, and Administrative Expenses | 14.36M | 13.25M | 16.14M | 20.09M | 25.02M | |||
| Operating Income | -25.22M | -25.06M | -32.07M | -31.68M | -29.03M | |||
| Interest Income/Expense | 364.37K | 140.00K | -7.54M | 500.00K | 1.85M | |||
| Non Recurring Items | 393.07K | -1.27M | 5.01M | -4.66M | -320.00K | |||
| Income Before Taxes | -21.15M | -26.20M | -34.60M | -35.84M | -27.50M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 10.00K | |||
| Net Income | -22.23M | -26.48M | -45.83M | -49.39M | -27.51M | |||
| EBITDA | -24.58M | -23.58M | -30.63M | -28.07M | -26.09M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.17 | -12.37 | -22.24 | -44.49 | -36.19 | |||
| Non GAAP EPS | N/A | N/A | -4.49 | -0.62 | -0.55 | |||
| Statistics | ||||||||
| Gross Profit Margin | -37.29% | -30.04% | -210.86% | -127.70% | 30.03% | |||
| Profit Margin | -614.19% | -556.30% | -2073.76% | -1776.62% | -124.42% | |||
| Operating Profit Margin | -696.82% | -526.47% | -1451.13% | -1139.57% | -131.30% | |||
All data in USD